Jump to content

Stocks


Jaitra

Recommended Posts

Press Release | Mumbai, October 13th, 2023 ImmunoACT announces the approval of India’s first CAR-T cell therapy, NexCAR19 (Actalycabtagene autoleucel), for the treatment of r/r B-cell lymphomas and leukemia from the Central Drugs Standard Control Organization (CDSCO).

Link to comment
Share on other sites

Press Release | Mumbai, October 13th, 2023 ImmunoACT announces the approval of India’s first CAR-T cell therapy, NexCAR19 (Actalycabtagene autoleucel), for the treatment of r/r B-cell lymphomas and leukemia from the Central Drugs Standard Control Organization (CDSCO).

----------------------------------------------------------------------------------------------------------------------------------------

CAR-T Cell therapy.. Immuno Act is the first company to get approval from CDSCO... The brand name is NexCAR19, wherein each treatment is valued at Rs.30lac-40lacs per sitting.. 

and now 27% of this company's stake... is in the hold of Laurus.. 

Link to comment
Share on other sites

5 minutes ago, roger7 said:

Press Release | Mumbai, October 13th, 2023 ImmunoACT announces the approval of India’s first CAR-T cell therapy, NexCAR19 (Actalycabtagene autoleucel), for the treatment of r/r B-cell lymphomas and leukemia from the Central Drugs Standard Control Organization (CDSCO).

----------------------------------------------------------------------------------------------------------------------------------------

CAR-T Cell therapy.. Immuno Act is the first company to get approval from CDSCO... The brand name is NexCAR19, wherein each treatment is valued at Rs.30lac-40lacs per sitting.. 

and now 27% of this company's stake... is in the hold of Laurus.. 

Good news 

But it’s neither directly benefiting Laurus nor directly related to it 

Link to comment
Share on other sites

1 hour ago, kanagalakiran said:

what is lower support for Laurus now ??

Rs. 383..

On 20th of Oct earnings call will be there.. i am expecting no great results - but their coverage on CDMO space+ NEXCAR future working + biosimilars trajectory will becoming pivotal points.. for future growth.

but on ensuing monday scrip should see some better swing.

Link to comment
Share on other sites

49 minutes ago, Aravind NBK said:

I entered at 249 for 5% move 20 days ainde 255 minchi velatla repu result em estharo

Result Baga ostadi ane rise ayyinatundi 200 nunchi 

 

Anni banks perigayi corona crisis tarvatha e bank peragadam tarvatha baga padipoyndi Micro finance crisis,floods  and suddenga Npa rise avvadam

400 touch ayyi 2 years ayyinattundi

 

Manchi bank antaru share emo :sleep:

Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • Recently Browsing   0 members

    • No registered users viewing this page.
×
×
  • Create New...